ULTRAVIST Drug Patent Profile
✉ Email this page to a colleague
When do Ultravist patents expire, and when can generic versions of Ultravist launch?
Ultravist is a drug marketed by Bayer Hlthcare and is included in two NDAs.
The generic ingredient in ULTRAVIST is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ULTRAVIST?
- What are the global sales for ULTRAVIST?
- What is Average Wholesale Price for ULTRAVIST?
Summary for ULTRAVIST
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for ULTRAVIST |
| What excipients (inactive ingredients) are in ULTRAVIST? | ULTRAVIST excipients list |
| DailyMed Link: | ULTRAVIST at DailyMed |
US Patents and Regulatory Information for ULTRAVIST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | ULTRAVIST (PHARMACY BULK) | iopromide | INJECTABLE;INJECTION | 021425-003 | Mar 12, 2004 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Hlthcare | ULTRAVIST 300 IN PLASTIC CONTAINER | iopromide | INJECTABLE;INJECTION | 020220-005 | Nov 18, 2008 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Hlthcare | ULTRAVIST 150 | iopromide | INJECTABLE;INJECTION | 020220-004 | May 10, 1995 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Hlthcare | ULTRAVIST 370 | iopromide | INJECTABLE;INJECTION | 020220-001 | May 10, 1995 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Hlthcare | ULTRAVIST (PHARMACY BULK) | iopromide | INJECTABLE;INJECTION | 021425-001 | Sep 20, 2002 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Hlthcare | ULTRAVIST (PHARMACY BULK) | iopromide | INJECTABLE;INJECTION | 021425-002 | Sep 20, 2002 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bayer Hlthcare | ULTRAVIST 300 | iopromide | INJECTABLE;INJECTION | 020220-002 | May 10, 1995 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
